Altitude sickness medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as nausea, dizzin..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Altitude sickness}} | |||
{{CMG}} | |||
==Overview== | |||
==Medical Therapy== | |||
The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as nausea, dizziness, fatigue or insomnia. | The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as nausea, dizziness, fatigue or insomnia. | ||
Line 13: | Line 18: | ||
# Treatment with Dexamethasone (8 mg PO/IM/IV, then, 4 mg q6h). | # Treatment with Dexamethasone (8 mg PO/IM/IV, then, 4 mg q6h). | ||
# Hyperbaric therapy: The patient is place in a portable altitude chamber or bag. | # Hyperbaric therapy: The patient is place in a portable altitude chamber or bag. | ||
==References== | |||
{{Reflist|2}} | |||
[[Category:Disease]] | |||
[[Category:Mountaineering]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Neurology]] | |||
{{WH}} | |||
{{WS}} |
Revision as of 03:16, 25 September 2012
Altitude sickness Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Altitude sickness medical therapy On the Web |
American Roentgen Ray Society Images of Altitude sickness medical therapy |
Risk calculators and risk factors for Altitude sickness medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as nausea, dizziness, fatigue or insomnia.
The management of mild acute mountain sickness includes:
- Discontinuation of Ascent.
- Treatment with Acetazolamide (250 mg q12h).
- Descent: The patient should descend below the point at which the symptoms occured.
Similarly, following steps are recommended for management of moderate acute mountain sickness:
- Immediate Descent.
- Administration of Oxygen (2-4 L/min).
- Treatment with Dexamethasone (8 mg PO/IM/IV, then, 4 mg q6h).
- Hyperbaric therapy: The patient is place in a portable altitude chamber or bag.